Tuesday - April 22, 2025
Statement from Aaron J. Kowalski, PhD, CEO of Breakthrough T1D, Formerly JDRF, the Leading Global Type 1 Diabetes Research and Advocacy Organization, on NIH Indirect Costs Cuts
February 09, 2025
NEW YORK, Feb. 9 -- Breakthrough T1D (formerly JDRF) a non-profit dedicated to funding type 1 diabetes research, posted the following news release:

* * *

Statement from Aaron J. Kowalski, PhD, CEO of Breakthrough T1D, Formerly JDRF, the Leading Global Type 1 Diabetes Research and Advocacy Organization, on NIH Indirect Costs Cuts

February 9, 2025

"Friday's announcement from the National Institutes of Health (NIH) that they are dramati . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products